{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:51:57Z","timestamp":1789905117034,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1124\/dmd.107.019398","type":"journal-article","created":{"date-parts":[[2008,4,18]],"date-time":"2008-04-18T00:55:52Z","timestamp":1208480152000},"page":"1315-1321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cellular Accumulation of Cholyl-Glycylamido-Fluorescein in Sandwich-Cultured Rat Hepatocytes: Kinetic Characterization, Transport Mechanisms, and Effect of Human Immunodeficiency Virus Protease Inhibitors"],"prefix":"10.1016","volume":"36","author":[{"given":"Zhi-wei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.107.019398_bib1","series-title":"Drug Transporters: Molecular Characterization and Role in Drug Disposition","article-title":"Drug transport in the liver","author":"Annaert","year":"2007"},{"key":"10.1124\/dmd.107.019398_bib2","first-page":"1277","article-title":"P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes","volume":"29","author":"Annaert","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.019398_bib3","first-page":"G382","article-title":"Expression and characterization of a functional rat liver Na+ bile acid cotransport system in COS-7 cells","volume":"266","author":"Boyer","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.107.019398_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.510270236","article-title":"Efficient in vitro vectorial transport of a fluorescent conjugated bile acid analogue by polarized hepatic hybrid WIF-B and WIF-B9 cells","volume":"27","author":"Bravo","year":"1998","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.019398_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.dld.2006.01.020","article-title":"Hepatotoxicity and antiretroviral therapy with protease inhibitors: a review","volume":"38","author":"Bruno","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1124\/dmd.107.019398_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/jhep.2000.8539","article-title":"Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2","volume":"32","author":"Fattinger","year":"2000","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.019398_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0026-895X(24)12255-9","article-title":"Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat","volume":"59","author":"Funk","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.019398_bib8","unstructured":"Hoetelmans R, Van der Sandt I, Pauw MD, Struble K, Peeters M, and Van der Geest R (2003) TMC114, a next generation HIV protease inhibitor: pharmacokinetics and safety following oral administration of multiple doses with and without low doses of ritonavir in healthy volunteers., in 10th Conference on Retroviruses and Opportunistic Infections; 2003 February 10\u201314; Abstract 549; Boston, MA."},{"key":"10.1124\/dmd.107.019398_bib9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1023\/B:PHAM.0000033018.97745.0d","article-title":"P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide","volume":"21","author":"Hoffmaster","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.107.019398_bib10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.510280231","article-title":"Transport of fluorescent bile acids by the isolated perfused rat liver: kinetics, sequestration, and mobilization","volume":"28","author":"Holzinger","year":"1998","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.019398_bib11","first-page":"1263","article-title":"Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat","volume":"26","author":"Holzinger","year":"1997","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.019398_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/toxsci\/kfg217","article-title":"Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats","volume":"76","author":"Kostrubsky","year":"2003","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.107.019398_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3565(24)35319-4","volume":"292","author":"Kouzuki","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.019398_bib14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1023\/A:1011994831139","article-title":"Partial maintenance of taurocholate uptake by adult rat hepatocytes cultured in a collagen sandwich configuration","volume":"15","author":"Liu","year":"1998","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.107.019398_bib15","first-page":"637","article-title":"Transport characteristics of three fluorescent conjugated bile acid analogs in isolated rat hepatocytes and couplets","volume":"22","author":"Maglova","year":"1995","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.019398_bib16","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1128\/AAC.01136-06","article-title":"Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatmentnaive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients","volume":"51","author":"Marin-Niebla","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.107.019398_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/mp0700357","article-title":"Use of sandwich-cultured hepatocytes to evaluate impaired bile acid transport as a mechanism of drug-induced hepatotoxicity","volume":"4","author":"Marion","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.107.019398_bib18","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1124\/jpet.106.102657","article-title":"Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes","volume":"318","author":"McRae","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.019398_bib19","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.510260641","article-title":"Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver","volume":"26","author":"Meier","year":"1997","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.019398_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejps.2005.07.001","article-title":"EUFEPS conference on Drug Transporters at Copenhagen: integrative approaches in ADME research","volume":"26","author":"Meijer","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.107.019398_bib21","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.105.008748","article-title":"Inhibition of bile acid transport across Na+\/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs","volume":"34","author":"Mita","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.019398_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00003088-200746090-00002","article-title":"Clinical pharmacokinetics of darunavir","volume":"46","author":"Rittweger","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.107.019398_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/AAC.00560-06","article-title":"Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteers","volume":"51","author":"Ruane","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.107.019398_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1014264614637","article-title":"Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport","volume":"19","author":"Shitara","year":"2002","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.107.019398_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/JCI116546","article-title":"Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes: role of ATP depletion and cytosolic free calcium","volume":"92","author":"Spivey","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.107.019398_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/mp0340136","article-title":"Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells","volume":"1","author":"Su","year":"2004","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.107.019398_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"10.1124\/dmd.107.019398_bib28","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2165\/00003495-200565160-00010","article-title":"Atazanavir: a review of its use in the management of HIV infection","volume":"65","author":"Swainston Harrison","year":"2005","journal-title":"Drugs"},{"key":"10.1124\/dmd.107.019398_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.102.043026","article-title":"Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation","volume":"304","author":"Tirona","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.019398_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2002.34133","article-title":"Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver","volume":"36","author":"Vavricka","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.019398_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0169-409X(99)00027-7","article-title":"Oral absorption of the HIV protease inhibitors: a current update","volume":"39","author":"Williams","year":"1999","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624017161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624017161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.107.019398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:25:46Z","timestamp":1739895946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624017161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0090955624017161"],"URL":"https:\/\/doi.org\/10.1124\/dmd.107.019398","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular Accumulation of Cholyl-Glycylamido-Fluorescein in Sandwich-Cultured Rat Hepatocytes: Kinetic Characterization, Transport Mechanisms, and Effect of Human Immunodeficiency Virus Protease Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.107.019398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}